Arezou Sayad1, Soudeh Ghafouri-Fard1, Rezvan Noroozi2, Mir Davood Omrani1,3, Maziar Ganji1, Romina Dastmalchi1, Mark Glassy4, Mohammad Taheri1,3. 1. Department of Medical Genetics, Shahid Beheshti University of Medical sciences, Tehran, Iran. 2. Phytochemistry Research Center, Shahid Beheshti University of Medical sciences, Tehran, Iran. 3. Urogenital Stem Cell Research Center, Shahid Beheshti University of Medical sciences, Tehran, Iran. 4. Hagiwara Institute of Health Integrated Medical Sciences Association Foundation, Oceanside, CA, United States.
Abstract
BACKGROUND: Autism spectrum disorders (ASDs) (MIM 209850) are a group of distinct neurodevelopmental disorders characterized by impaired social interactions and communication abilities and abnormal repetitive activities. Many genetic variants have been shown to be associated with ASD. Channelopathies are among putative culprits in the pathogenesis of many neurodevelopmental disorders, including autism. The calcium channel, voltage-dependent, L type, alpha 1C subunit gene (CACNA1C) encodes an alpha-1 subunit of a voltage-dependent calcium channel. Genetic variants within this gene have been associated with psychiatric disorders including Autism Spectrum Disorders (ASD). Our aim was to determine whether the SNPs rs1006737, rs4765905, and rs4765913 were associated with ASD in an Iranian population. METHODS: In the present case-control study we investigated the associations of rs1006737, rs4765905, and rs4765913 polymorphisms within CACNA1C and the risk of ASD in a population of 529 Iranian ASD patients and 480 age, gender, and ethnicity-matched healthy subjects. RESULTS: None of these SNPs were associated with ASD risk in the assessed population. Although previous studies have shown an association between these polymorphisms and psychiatric disorders and an association between rs4765905 and ASD, we did not replicate those results in our study. CONCLUSION: Our data indicate that these CACNA1C variants are not involved in the pathogenesis of ASD in the Iranian population.
BACKGROUND: Autism spectrum disorders (ASDs) (MIM 209850) are a group of distinct neurodevelopmental disorders characterized by impaired social interactions and communication abilities and abnormal repetitive activities. Many genetic variants have been shown to be associated with ASD. Channelopathies are among putative culprits in the pathogenesis of many neurodevelopmental disorders, including autism. The calcium channel, voltage-dependent, L type, alpha 1C subunit gene (CACNA1C) encodes an alpha-1 subunit of a voltage-dependent calcium channel. Genetic variants within this gene have been associated with psychiatric disorders including Autism Spectrum Disorders (ASD). Our aim was to determine whether the SNPs rs1006737, rs4765905, and rs4765913 were associated with ASD in an Iranian population. METHODS: In the present case-control study we investigated the associations of rs1006737, rs4765905, and rs4765913 polymorphisms within CACNA1C and the risk of ASD in a population of 529 Iranian ASD patients and 480 age, gender, and ethnicity-matched healthy subjects. RESULTS: None of these SNPs were associated with ASD risk in the assessed population. Although previous studies have shown an association between these polymorphisms and psychiatric disorders and an association between rs4765905 and ASD, we did not replicate those results in our study. CONCLUSION: Our data indicate that these CACNA1C variants are not involved in the pathogenesis of ASD in the Iranian population.
Authors: Shambhu Bhat; David T Dao; Chantelle E Terrillion; Michal Arad; Robert J Smith; Nikolai M Soldatov; Todd D Gould Journal: Prog Neurobiol Date: 2012-06-15 Impact factor: 11.685
Authors: M L Hamshere; J T R Walters; R Smith; A L Richards; E Green; D Grozeva; I Jones; L Forty; L Jones; K Gordon-Smith; B Riley; F A O'Neill; T O'Neill; K S Kendler; P Sklar; S Purcell; J Kranz; D Morris; M Gill; P Holmans; N Craddock; A Corvin; M J Owen; M C O'Donovan Journal: Mol Psychiatry Date: 2012-05-22 Impact factor: 15.992
Authors: P Sklar; J W Smoller; J Fan; M A R Ferreira; R H Perlis; K Chambert; V L Nimgaonkar; M B McQueen; S V Faraone; A Kirby; P I W de Bakker; M N Ogdie; M E Thase; G S Sachs; K Todd-Brown; S B Gabriel; C Sougnez; C Gates; B Blumenstiel; M Defelice; K G Ardlie; J Franklin; W J Muir; K A McGhee; D J MacIntyre; A McLean; M VanBeck; A McQuillin; N J Bass; M Robinson; J Lawrence; A Anjorin; D Curtis; E M Scolnick; M J Daly; D H Blackwood; H M Gurling; S M Purcell Journal: Mol Psychiatry Date: 2008-03-04 Impact factor: 15.992
Authors: E K Green; D Grozeva; I Jones; L Jones; G Kirov; S Caesar; K Gordon-Smith; C Fraser; L Forty; E Russell; M L Hamshere; V Moskvina; I Nikolov; A Farmer; P McGuffin; P A Holmans; M J Owen; M C O'Donovan; N Craddock Journal: Mol Psychiatry Date: 2009-07-21 Impact factor: 15.992
Authors: Manuel A R Ferreira; Michael C O'Donovan; Yan A Meng; Ian R Jones; Douglas M Ruderfer; Lisa Jones; Jinbo Fan; George Kirov; Roy H Perlis; Elaine K Green; Jordan W Smoller; Detelina Grozeva; Jennifer Stone; Ivan Nikolov; Kimberly Chambert; Marian L Hamshere; Vishwajit L Nimgaonkar; Valentina Moskvina; Michael E Thase; Sian Caesar; Gary S Sachs; Jennifer Franklin; Katherine Gordon-Smith; Kristin G Ardlie; Stacey B Gabriel; Christine Fraser; Brendan Blumenstiel; Matthew Defelice; Gerome Breen; Michael Gill; Derek W Morris; Amanda Elkin; Walter J Muir; Kevin A McGhee; Richard Williamson; Donald J MacIntyre; Alan W MacLean; Clair David St; Michelle Robinson; Margaret Van Beck; Ana C P Pereira; Radhika Kandaswamy; Andrew McQuillin; David A Collier; Nicholas J Bass; Allan H Young; Jacob Lawrence; I Nicol Ferrier; Adebayo Anjorin; Anne Farmer; David Curtis; Edward M Scolnick; Peter McGuffin; Mark J Daly; Aiden P Corvin; Peter A Holmans; Douglas H Blackwood; Hugh M Gurling; Michael J Owen; Shaun M Purcell; Pamela Sklar; Nick Craddock Journal: Nat Genet Date: 2008-09 Impact factor: 38.330